Nova Southeastern University

82 total trials 68 currently recruiting 11 completed

Trial Pipeline

RECRUITING NA

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

NCT07187388

RECRUITING NA

The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program

NCT06652503

RECRUITING NA

Mitigating Response to Stressors in Pregnant Women

NCT06718907

RECRUITING

Substance Use Treatment and Its Role in Supporting Social Cognition

NCT06535919

RECRUITING NA

Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners

NCT06581523

RECRUITING NA

Mix of Demineralized Freeze-Dried Bone Allograft and Deproteinized Bovine Bone Mineral: a Possible Solution for Alveolar Ridge Preservation?

NCT06275789

RECRUITING Early Phase 1

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

NCT04987775

RECRUITING NA

Combined Respiratory Training in Persons With ALS

NCT05913882

RECRUITING NA

Investigating Cardiac Health of Adults With Trauma

NCT05700201

RECRUITING Phase 1

Rh-PDGF vs EMD for Treatment of Intra-bony Defects

NCT05442034

RECRUITING Phase 2

The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT06211062

RECRUITING Phase 2

Study of Bacopa in Gulf War Illness Patients

NCT04927338

RECRUITING NA

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

NCT05522972

RECRUITING NA

A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics

NCT02157025

ACTIVE NOT RECRUITING NA

Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition

NCT06269614

ACTIVE NOT RECRUITING Phase 1

TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset

NCT04254627

ACTIVE NOT RECRUITING NA

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

NCT02086890

COMPLETED NA

Teach-Back Discharge Education to Improve Self-Care and Reduce 30-Day Readmissions in Heart Failure Patients

NCT07280208

COMPLETED NA

The Effects of Gyngerlean Supplementation on Energy Expenditure

NCT06805201

COMPLETED NA

MBSR Programs to Reduce Compassion Fatigue in Nurses

NCT06436469

COMPLETED NA

Computer Cognitive Training for Post-acute COVID-19 Syndrome

NCT05338749

COMPLETED NA

Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2

NCT03192722

COMPLETED NA

Abutment Macro Design and Peri-implant Tissues

NCT02546713

COMPLETED NA

Shoulder Eccentric External Rotator Training for Subacromial Pain Syndrome

NCT02153827

COMPLETED

The Effectiveness of Diagnosis and Treatment of Thoracic Outlet Syndrome

NCT01342068

COMPLETED NA

Motiv82Change: an HIV Prevention Study for Young Latino Men

NCT00877695

COMPLETED NA

Effects of OA Decompression on the Autonomic Nervous System

NCT00403936

COMPLETED NA

Effect of Cranial Osteopathy on Visual Function

NCT00510562

What the Pipeline for Nova Southeastern University Shows

According to the ClinicalTrials.gov registry, Nova Southeastern University is linked to 82 US clinical trials across every stage of research activity. Of those, 68 studies are currently recruiting — about 83% of the sponsor's indexed portfolio — and 11 are already marked complete, representing roughly 13% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.

The phase mix for Nova Southeastern University reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 5 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.

The top therapeutic focus area indexed for Nova Southeastern University is Gulf War Illness with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial